drugset / Trial / NCT01446497

Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma

NCT01446497

Phase 4 Unknown 22 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Purpose To evaluate efficacy and safety of combigan(Brimonidine/Timolol) and 0.5% Timoptic (Timolol) ophthalmic solutions in normal tension glaucoma patients.

Timeline

Start
2010-10
Primary completion
2011-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule Other
Comparator Timolol Other / unclassified Other

Indications